Success Metrics

Clinical Success Rate

88.9%

Based on 8 completed trials

Completion Rate

89%(8/9)

Active Trials

0(0%)

Results Posted

75%(6 trials)

Terminated

1(11%)

Phase Distribution

Ph phase_3

11%

Ph not_applicable

11%

Ph phase_4

44%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

3(33.3%)

Phase 3Large-scale testing

1(11.1%)

Phase 4Post-market surveillance

4(44.4%)

N/ANon-phased studies

1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(8)

Terminated(1)

Detailed Status

Completed8

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

88.9%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (33.3%)

Phase 31 (11.1%)

Phase 44 (44.4%)

N/A1 (11.1%)

Trials by Status

completed889%

terminated111%

Recent Activity

0 active trials

Showing 5 of 9

completedphase_1

Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis

NCT00396084

completedphase_4

Topical Antibiotics and Intravitreous Injections

NCT00410891

completedphase_4

Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever

NCT01421693

terminatedphase_3

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis

NCT01330355

completednot_applicable

Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)

NCT00414011

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT00396084Phase 1

Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis

Completed

NCT00410891Phase 4

Topical Antibiotics and Intravitreous Injections

Completed

NCT01421693Phase 4

Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever

Completed

NCT01330355Phase 3

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis

Terminated

NCT00414011Not Applicable

Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)

Completed

NCT00824070Phase 1

Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects

Completed

NCT00905762Phase 1

Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation

Completed

NCT00464438Phase 4

A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

Completed

NCT00407017Phase 4

Therapeutic Variables in Cataract Surgery